TVTX logo

Travere Therapeutics (TVTX) Current Assets

Annual Current Assets

$616.77 M
+$130.34 M+26.79%

31 December 2023

TVTX Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$324.74 M
-$44.24 M-11.99%

30 September 2024

TVTX Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TVTX Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+26.8%-52.7%
3 y3 years+50.3%-43.9%
5 y5 years+24.4%-26.1%

TVTX Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+50.3%-52.7%at low
5 y5 yearsat high+50.3%-52.7%at low
alltimeall timeat high>+9999.0%-52.7%>+9999.0%

Travere Therapeutics Current Assets History

DateAnnualQuarterly
Sept 2024
-
$324.74 M(-12.0%)
June 2024
-
$368.98 M(-23.3%)
Mar 2024
-
$481.08 M(-22.0%)
Dec 2023
$172.14 M(-7.5%)
$616.77 M(-10.1%)
Sept 2023
-
$686.23 M(+26.6%)
June 2023
-
$542.05 M(-10.4%)
Mar 2023
-
$604.90 M(+24.4%)
Dec 2022
$186.11 M(-4.0%)
$486.44 M(-9.1%)
Sept 2022
-
$534.84 M(-8.9%)
June 2022
-
$586.78 M(-7.0%)
Mar 2022
-
$631.09 M(+8.3%)
Dec 2021
$193.77 M(-1.7%)
$582.83 M(+0.6%)
Sept 2021
-
$579.08 M(+5.3%)
June 2021
-
$549.80 M(-2.7%)
Mar 2021
-
$565.04 M(+37.7%)
Dec 2020
$197.03 M(+12.1%)
$410.41 M(-17.5%)
Sept 2020
-
$497.68 M(-1.6%)
June 2020
-
$505.56 M(+24.3%)
Mar 2020
-
$406.63 M(-5.2%)
Dec 2019
$175.74 M(-17.7%)
$429.06 M(-2.4%)
Sept 2019
-
$439.72 M(-3.8%)
June 2019
-
$457.01 M(-3.9%)
Mar 2019
-
$475.51 M(-4.1%)
Dec 2018
$213.48 M(+9.7%)
$495.68 M(-1.5%)
Sept 2018
-
$502.99 M(+80.3%)
June 2018
-
$278.92 M(-2.7%)
Mar 2018
-
$286.80 M(-12.0%)
Dec 2017
$194.54 M
$325.81 M(+0.1%)
DateAnnualQuarterly
Sept 2017
-
$325.34 M(+1.8%)
June 2017
-
$319.66 M(-0.8%)
Mar 2017
-
$322.40 M(-3.0%)
Dec 2016
$192.93 M(-8.3%)
$332.35 M(-3.0%)
Sept 2016
-
$342.59 M(+14.1%)
June 2016
-
$300.16 M(+0.8%)
Mar 2016
-
$297.74 M(-1.4%)
Dec 2015
$210.33 M(+114.3%)
$301.93 M(+0.7%)
Sept 2015
-
$299.95 M(+22.6%)
June 2015
-
$244.74 M(+4.8%)
Mar 2015
-
$233.54 M(+525.6%)
Dec 2014
$98.14 M(+655.0%)
$37.33 M(-17.8%)
Sept 2014
-
$45.44 M(-14.9%)
June 2014
-
$53.40 M(+728.8%)
Mar 2014
-
$6.44 M(-14.1%)
Dec 2013
$13.00 M(+451.2%)
$7.50 M(-55.5%)
Sept 2013
-
$16.85 M(+4066.1%)
June 2013
-
$404.40 K(-84.7%)
Mar 2013
-
$2.64 M(>+9900.0%)
Dec 2012
$2.36 M(>+9900.0%)
-
Nov 2012
-
$3900.00(0.0%)
Aug 2012
-
$3900.00(0.0%)
May 2012
-
$3900.00(0.0%)
Feb 2012
-
$3900.00(0.0%)
Feb 2012
$0.00(0.0%)
-
Nov 2011
-
$3900.00(0.0%)
Aug 2011
-
$3900.00(-2.5%)
Feb 2011
$0.00
$4000.00

FAQ

  • What is Travere Therapeutics annual total current assets?
  • What is the all time high annual current assets for Travere Therapeutics?
  • What is Travere Therapeutics annual current assets year-on-year change?
  • What is Travere Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Travere Therapeutics?
  • What is Travere Therapeutics quarterly current assets year-on-year change?

What is Travere Therapeutics annual total current assets?

The current annual current assets of TVTX is $616.77 M

What is the all time high annual current assets for Travere Therapeutics?

Travere Therapeutics all-time high annual total current assets is $616.77 M

What is Travere Therapeutics annual current assets year-on-year change?

Over the past year, TVTX annual total current assets has changed by +$130.34 M (+26.79%)

What is Travere Therapeutics quarterly total current assets?

The current quarterly current assets of TVTX is $324.74 M

What is the all time high quarterly current assets for Travere Therapeutics?

Travere Therapeutics all-time high quarterly total current assets is $686.23 M

What is Travere Therapeutics quarterly current assets year-on-year change?

Over the past year, TVTX quarterly total current assets has changed by -$361.49 M (-52.68%)